Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are starting Mounjaro and take a hormonal contraceptive, there is one specific step to take for the first few weeks: add a non-oral method of contraception alongside your pill. Mounjaro (tirzepatide) slows gastric emptying, which can reduce how reliably the body absorbs an oral contraceptive pill, potentially lowering its effectiveness. This applies when you start treatment and again each time your dose is increased. It is a practical, manageable precaution, not a reason to avoid treatment — but it is one that your prescriber needs to know about before you begin. As a prescription-only medicine, Mounjaro is assessed individually; a GPhC-registered Independent Prescriber reviews your full health picture, including any contraceptive you take, before anything is dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scene: your Mounjaro pen has arrived, everything feels organised, and then a friend mentions she had to change her contraception when she started. You go looking for answers and find conflicting information.
Here is the straightforward picture. Tirzepatide (the active ingredient in Mounjaro) is a dual GIP and GLP-1 receptor agonist that slows the rate at which food, liquid and medicines move through the stomach. For most purposes that slowing is part of why treatment works: it prolongs fullness and reduces appetite. For an oral contraceptive pill, though, delayed gastric transit can mean the pill is absorbed more slowly and less completely than the manufacturer designed for, which may leave a small gap in protection.
The MHRA and NHS England's guidance on weight-management injections is clear on the window that matters: add a reliable non-oral contraceptive method for the first four weeks of Mounjaro treatment, and then again for four weeks after every dose increase. You are not being asked to stop the pill or switch permanently, just to cover those specific transition periods with a backup. Condoms are the most practical choice for most people, though your GP or sexual health clinic can advise on alternatives.
This applies at every step of the tirzepatide titration schedule, from 2.5 mg through to the higher maintenance doses, because each increase triggers a fresh phase of gastric adjustment.
The short answer is no, and the reason is worth understanding, because it removes a lot of unnecessary worry for many people.
The pill's absorption problem arises specifically because the tablet has to be processed through the digestive system. Non-oral contraceptives do not share that route. The contraceptive implant delivers hormones directly through the skin into the bloodstream; the hormonal coil (IUS) acts locally in the uterus; the injection goes straight into muscle. None of these methods rely on the stomach's transit speed, which is why the implant and similar non-oral methods are not affected by Mounjaro in the same way.
If you already use a patch, injection, implant or hormonal coil, the current guidance does not require an additional backup method because of Mounjaro alone. That said, it is always sensible to mention all your current medicines and contraceptive choices when you complete your consultation, so your prescriber can give you an accurate picture for your specific situation rather than a generic one.
There is a separate point worth noting about pregnancy planning. MHRA guidance advises that women should use effective contraception throughout treatment and for a period after stopping before actively trying to conceive. If that timing is relevant to you, it is worth raising during your consultation rather than working it out after you have already started.
People reasonably ask whether Mounjaro cancels out the pill's contraceptive effect, or simply reduces it. The evidence does not suggest the pill stops working entirely, rather, the absorption is less predictable during periods of gastric-emptying change. That is a meaningful distinction, because it means the backup method is a precaution against a possible gap, not a response to a known failure.
For the same reason, the four-week windows in the guidance are not arbitrary. The first pen introduces the gastric-slowing effect; the body adjusts over the following weeks. Each dose step is, in effect, a new introduction at a higher level. Once absorption has stabilised at a given dose, the interaction risk settles with it.
Some people taking the progesterone-only pill (sometimes called the mini-pill) have asked whether the guidance differs for them. The mechanism of concern (gastric transit affecting oral tablet absorption) applies regardless of the pill type. If you take any oral contraceptive pill, the four-week backup recommendation applies in the same way.
Thinking about the timing of all this is genuinely helpful. If you are planning to start Mounjaro and your next pill pack begins mid-month, or you have a holiday coming up that makes switching methods complicated, building a few days of lead time into your plan is sensible. A conversation with your GP or sexual health nurse ahead of starting is straightforward to arrange and worth doing.
Every Mounjaro consultation at nume is personally reviewed by a GPhC-registered Independent Prescriber who reads your health history and medication list before a prescription is issued. That includes any contraceptive you are currently taking. If the pill is on your list, you will receive specific guidance on the backup-method window as part of your clinical review, not as an afterthought.
For anyone curious about the broader treatment picture (how Mounjaro works, what to expect at each stage, or how private access compares to NHS routes) the Mounjaro overview page covers the clinical detail thoroughly. If cost is on your mind, the treatment cost section explains what is included in a private prescription and how to read the pricing landscape honestly.
The contraception question is one our prescribers field regularly, and it is a good one to ask. Raising it clearly in your consultation means you can start treatment with the full picture in front of you rather than working it out afterwards. When you feel ready to explore whether treatment is suitable for you, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.